Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India’s Piramal Life Considers New Ties To MNCs

This article was originally published in PharmAsia News

Executive Summary

Piramal Life Sciences of India is considering agreements with multinational drug makers in research on anti-inflammation and infectious-disease drugs. Piramal Life, which already has formed similar arrangements in cancer and diabetes research, now is considering talks with other companies about joint efforts in the other two areas. CEO Somesh Sharma said the talks are part of the firm's policy to consider "mutually beneficial research alliances." (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts